Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

3 High-Yield Stocks Still Worth Buying


3 High-Yield Stocks Still Worth Buying

Who doesn't like free money? While they may be somewhat forgotten as the stock market hits seemingly one new high after another, high-yield dividend stocks play an important role in providing steady income for retirees and helping investors hedge against inevitable stock market declines.

But not all high-yield stocks are created equal. Some have fallen in recent quarters as a result of genuine concerns about their business models, while others have simply been given a bad rap. It's this latter group that could be worth a closer inspection. 

According to three of our Foolish investors, coal producer Alliance Resource Partners (NASDAQ: ARLP), massive retail chain Target Corporation (NYSE: TGT), and U.K.-based pharma giant GlaxoSmithKline (NYSE: GSK), are three high-yield stocks that may still be worth buying. 

Continue reading


Source: Fool.com

GSK plc ADR Stock

€36.00
-2.700%
We can see a decrease in the price for GSK plc ADR. Compared to yesterday it has lost -€1.000 (-2.700%).
With 6 Buy predictions and not the single Sell prediction the community is currently very high on GSK plc ADR.
With a target price of 49 € there is a positive potential of 36.11% for GSK plc ADR compared to the current price of 36.0 €.
Like: 0
GSK
Share

Comments